Profitability
Weight: 25%
F
14
- 5yr Avg ROIC 1.9%
- Operating Margin Trend -2.37 pp/yr
CAI
Caris Life Sciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -44.6%
- 5yr Share-Count CAGR 58.9%
Growth Quality
Weight: 25%
B+
77
- 5yr Revenue CAGR 11.8%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
D
36
- 5yr FCF Margin -51.6%
- 5yr FCF/NI Conversion 2.08x
Balance Sheet
Weight: 10%
B
70
- Net Debt / EBITDA -37.00x
- Interest Coverage (EBIT/Int) -0.20x
- Altman Z-Score 8.48
Stability
Weight: 5%
C-
44
- EPS Volatility (σ/μ) 0.61
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 6
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 4 gurus held; 1 added; 1 trimmed; 3 full exits.
- Holders
- 3 -1
- Avg Δ position
- -10.0%
- New buys
- 0
- Full exits
- 3